Waukegan、ILにおける肺がんの臨床試験
Waukeganとその周辺地域（約30マイル以内）の拠点で、肺がんに関する16件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
被験者募集中第3相
- AMG Libertyville - Oncology, Libertyville · 8マイル先
- Condell Memorial Hospital, Libertyville · 8マイル先
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
被験者募集中第3相
- AMG Libertyville - Oncology, Libertyville · 8マイル先
- Condell Memorial Hospital, Libertyville · 8マイル先
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
被験者募集中第3相
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7マイル先
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10マイル先
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- AMG Libertyville - Oncology, Libertyville · 8マイル先
- Condell Memorial Hospital, Libertyville · 8マイル先
Empathic Communication Skills (ECS) Training
被験者募集中健康なボランティア歓迎
- Advocate Health Care Network, Libertyville · 8マイル先
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
被験者募集中第3相
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7マイル先
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10マイル先
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
被験者募集中第3相
- Advocate Medical Group - Libertyville Oncology, Libertyville · 8マイル先
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
被験者募集中第1相
- City of Hope - Chicago, Zion · 6マイル先
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
被験者募集中第3相
- City of Hope® Cancer Center Chicago, Zion · 6マイル先
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
被験者募集中第3相
- Midwestern Regional Medical Center, Zion · 6マイル先
- AMG Libertyville - Oncology, Libertyville · 8マイル先
- Condell Memorial Hospital, Libertyville · 8マイル先
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
被験者募集中
- Captain James A. Lovell Federal Health Care Center, North Chicago · 3マイル先
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
被験者募集中第2相
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7マイル先
- AMG Libertyville - Oncology, Libertyville · 8マイル先
- Condell Memorial Hospital, Libertyville · 8マイル先
- 他1件
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2/3相
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7マイル先
- AMG Libertyville - Oncology, Libertyville · 8マイル先
- Condell Memorial Hospital, Libertyville · 8マイル先
- 他1件
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2相
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7マイル先
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10マイル先
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
被験者募集中第2相
- City of Hope at Chicago, Zion · 6マイル先
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
被験者募集中観察研究
- AMG Libertyville - Oncology, Libertyville · 8マイル先
- Condell Memorial Hospital, Libertyville · 8マイル先
他の都市における肺がんの試験
- Houston, TX78件の研究
- Boston, MA62件の研究
- New York City, NY60件の研究
- Los Angeles, CA45件の研究
- Arlington, VA41件の研究
- Washington, DC41件の研究
- Chicago, IL41件の研究
- Nashville, TN40件の研究
- Baltimore, MD40件の研究
- St. Louis, MO39件の研究
- Columbus, OH37件の研究
- Philadelphia, PA36件の研究
Waukeganにおける他の研究
- 非小細胞肺癌16件の研究
- 乳がん12件の研究
- 潰瘍性大腸炎7件の研究
- 腎臓がん（腎細胞がん）7件の研究
- 卵巣がん6件の研究
- 転移性癌6件の研究
- 頭頸部扁平上皮癌6件の研究
- 大腸癌6件の研究
- 前立腺がん6件の研究
- 悪性黒色腫5件の研究
- 急性骨髄性白血病5件の研究
- クローン病5件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。